Deepinder P. Singh

Deepinder P. Singh, MD, is an Associate Professor in the Department of Radiation Oncology at the University of Rochester Medical Center, where he also serves as a faculty member in the UR Medicine Faculty Group. Specializing in stereotactic body radiation therapy and brachytherapy for lung cancers, as well as treating nasopharyngeal, oropharyngeal, oral cavity, laryngeal, and hypopharyngeal cancers, Dr. Singh combines clinical expertise with significant research contributions.

Education includes an MBBS from Indira Gandhi Medical College, Shimla (1981), followed by residencies and fellowships at the University of Rochester Medical Center (2001-2009) and Indian institutions (1982-1989). His clinical focus centers on

• Lung cancer radiotherapy
• Head and neck oncology
• SBRT for oligometastatic disease
• Brachytherapy applications

Research trends over the last decade show specialization in stereotactic body radiation therapy for lung tumors, dosimetric optimization in complex cancer scenarios, and management of metastatic patterns following radiation treatments. Key subfields include tumor-specific radiation protocols, adaptive therapy planning, and radiation-induced complications in thoracic and head/neck cancers.

Scientific recognition includes

• Fellow (2024)
• Certificate of Appreciation (2020)
• Multiple Educator of the Year awards (2012-2020)
• Bronze Star (2016-2019)

As a clinical researcher, Dr. Singh leads major trials like the Phase III SBRT+chemoradiation comparison for locally advanced NSCLC and the 3 vs 5-fraction SBRT protocol. His teaching contributions are evidenced through frequent appearances as Educator of the Year at the University of Rochester Medical Center.